Jack Ryan

Jack is a Corporate associate in our Dublin office. He advises private equity sponsors, venture capital investors and corporates on a wide range of domestic and cross-border transactions.

Jack regularly advises institutional investors, portfolio companies, management teams and trade clients on acquisitions, disposals, investments, joint ventures and corporate restructurings, as well as general corporate governance matters.

CV

Since 2025 Associate, Taylor Wessing

2022 - 2025 Trainee Solicitor, Byrne Wallace Shields

Carrière

Since 2025 Associate, Taylor Wessing

2022 - 2025 Trainee Solicitor, Byrne Wallace Shields

Formation

2025 Admitted as a lawyer, Ireland

2019 LLM, University of Galway

2018 LLB, University of Limerick

Actualités et publications récentes

View Jack's insights

Cliquer ici pour en savoir plus

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising on the sale of DreamTec Systems to FleetGO

14 janvier 2026

par plusieurs auteurs

Jack Ryan

Expertise

Services et Groupes

CV

Carrière

Formation

Actualités et publications récentes

Advising on the sale of DreamTec Systems to FleetGO

Jack Ryan

Expertise

Services et Groupes

CV

Carrière

Formation

Actualités et publications récentes

Advising on the sale of DreamTec Systems to FleetGO

Related news & insights

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

Advising on Sona's US$45 million Series B funding

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

German Federal Court of Justice promotes Legal Certainty for Leaver Clauses in Management Equity Programs in the Private Equity Sector

Carbon Border Adjustment Mechanism (CBAM): From Reporting to Real Financial Impact

Sustainability Stories: Notpla

EU Inc. – The 28th Regime: How the European Commission intends to revolutionise the formation of companies

Investing in the German Audit and Tax Advisory Market – Opportunity Amid Regulatory Debate

More Than Share and Asset Deals: Innovative Transaction Structures for MedTech Companies

Advising on Tropic Biosciences' US$105 million Series C financing

Autres avocats qui pourraient vous intéresser

Rendez-vous à